Application no. and date | 15724354.4 (espacenet) (Federated) (European Patent Register), 20150511 | Patent/reg. no. and date | DK/EP 3142701, 20180627 | Publication date | 20170322 | Priority no. and date | GB 201408384, 20140512, GB 201417719, 20141007 | EP pub. no. and date |
EP 3142701 20170322 | Effective date | | Applicant/owner | Verona Pharma PLC, One Central Square
Cardiff CF10 1FS, GB | Applicant ref. no. | P81802742DK00E | Inventor | ABBOTT-BANNER, Katharine, Verona Pharma PLC 3 More London Riverside
London Greater London SE1 2RE, GB, HANRAHAN, John, c/o McGill University McIntyre Medical Sciences Building 3655 Promenade Sir William Osler
Montreal Québec H3G 1Y6, CA, THOMAS, David, c/o McGill University McIntyre Medical Sciences Building 3655 Promenade Sir William Osler
Montreal Québec H3G 1Y6, CA | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 31/405 (2006.01) , A61K 31/47 (2006.01) , A61K 31/517 (2006.01) , A61K 45/06 (2006.01) , A61P 11/06 (2006.01) | Title | Ny behandling | Int. application no. | GB2015051377 | Int. publication no. | WO2015173551 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|